Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.080 | 20 | 3670579 | non coding transcript exon variant | G/C;T | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.925 | 0.080 | 20 | 3674438 | 3 prime UTR variant | C/T | snv | 0.47 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.120 | 20 | 3667731 | upstream gene variant | A/G;T | snv |
|
Skin and Connective Tissue Diseases | 0.010 | < 0.001 | 1 | 2008 | 2008 | ||||||||
|
0.925 | 0.120 | 20 | 3667731 | upstream gene variant | A/G;T | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.827 | 0.120 | 20 | 3671095 | synonymous variant | C/A;G | snv | 4.7E-06; 0.29 |
|
Respiratory Tract Diseases | 0.010 | < 0.001 | 1 | 2014 | 2014 | |||||||
|
0.827 | 0.120 | 20 | 3671095 | synonymous variant | C/A;G | snv | 4.7E-06; 0.29 |
|
Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.827 | 0.120 | 20 | 3671095 | synonymous variant | C/A;G | snv | 4.7E-06; 0.29 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | < 0.001 | 1 | 2015 | 2015 | |||||||
|
0.827 | 0.120 | 20 | 3671095 | synonymous variant | C/A;G | snv | 4.7E-06; 0.29 |
|
Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
1.000 | 0.080 | 20 | 3670047 | non coding transcript exon variant | C/T | snv | 0.20 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.080 | 20 | 3670622 | non coding transcript exon variant | G/A | snv | 0.63 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.882 | 0.120 | 20 | 3671560 | intron variant | G/A | snv | 0.17 | 0.25 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
|
0.882 | 0.120 | 20 | 3671560 | intron variant | G/A | snv | 0.17 | 0.25 |
|
Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
0.882 | 0.120 | 20 | 3671560 | intron variant | G/A | snv | 0.17 | 0.25 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
|
0.851 | 0.160 | 20 | 3669074 | intron variant | T/C | snv | 0.65 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.851 | 0.160 | 20 | 3669074 | intron variant | T/C | snv | 0.65 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.851 | 0.160 | 20 | 3669074 | intron variant | T/C | snv | 0.65 |
|
Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.851 | 0.160 | 20 | 3669074 | intron variant | T/C | snv | 0.65 |
|
Skin and Connective Tissue Diseases | 0.010 | < 0.001 | 1 | 2008 | 2008 | |||||||
|
1.000 | 0.080 | 20 | 3668784 | 3 prime UTR variant | A/G;T | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.925 | 0.080 | 20 | 3669156 | intron variant | G/A;C | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.851 | 0.160 | 20 | 3668514 | 3 prime UTR variant | C/G | snv | 0.71 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.020 | 1.000 | 2 | 2013 | 2015 | |||||||
|
0.925 | 0.080 | 20 | 3670579 | non coding transcript exon variant | G/C;T | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.020 | 1.000 | 2 | 2008 | 2013 | ||||||||
|
0.925 | 0.080 | 20 | 3674438 | 3 prime UTR variant | C/T | snv | 0.47 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.020 | 1.000 | 2 | 2009 | 2018 | |||||||
|
0.827 | 0.120 | 20 | 3671095 | synonymous variant | C/A;G | snv | 4.7E-06; 0.29 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.020 | 0.500 | 2 | 2015 | 2017 | |||||||
|
0.925 | 0.080 | 20 | 3669156 | intron variant | G/A;C | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.020 | 1.000 | 2 | 2013 | 2019 | ||||||||
|
0.882 | 0.120 | 20 | 3669558 | missense variant | G/A | snv | 0.13 | 0.14 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.030 | 1.000 | 3 | 2009 | 2019 |